Table 3.

Comparison of IL-6 and PANSS in the treatment group and the control group

Variable	Timeline	Treatment (N=21)	p	Control (N=21)	p
IL-6 (pg/mL)			0.001*		0.001*
	Baseline	11.2±1.41		11.0±2.16
	6th week	7.59±1.11		8.54±1.79
PANSS			0.001**		0.001**
	Early week	98.0±3.13		97.7±2.76
	2nd week	87.8±4.24		90.0±6.93
	4th week	79.5±6.42		86.8±8.72
	6th week	72.2±6.28		82.9±9.59

Values are presented as mean±standard deviation.

^*significant p<0.05 (paired t-test);

^**significant p<0.05 (Friedman test).

PANSS, Positive and Negative Syndrome Scale